Barry E. Greene
2017 - Alnylam Pharmaceuticals
In 2017, Barry E. Greene earned a total compensation of $944.1K as President at Alnylam Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $365,814 |
|---|---|
| Salary | $562,792 |
| Other | $15,539 |
| Total | $944,145 |
Greene received $562.8K in salary, accounting for 60% of the total pay in 2017.
Greene also received $365.8K in non-equity incentive plan and $15.5K in other compensation.
Rankings
In 2017, Barry E. Greene's compensation ranked 9,235th out of 14,666 executives tracked by ExecPay. In other words, Greene earned more than 37.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,235 out of 14,666 | 37th |
Division Manufacturing | 3,547 out of 5,768 | 39th |
Major group Chemicals And Allied Products | 1,217 out of 2,074 | 41st |
Industry group Drugs | 978 out of 1,730 | 44th |
Industry Pharmaceutical Preparations | 768 out of 1,329 | 42nd |
Source: SEC filing on March 23, 2018.
Greene's colleagues
We found six more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2017.
2017
Manmeet Soni
Alnylam Pharmaceuticals
Chief Financial Officer
2017
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2017
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2017
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2017
Michael Mason
Alnylam Pharmaceuticals
Vice President of Finance and Treasurer former principal financial officer
2017
David-Alexandre Gros
Alnylam Pharmaceuticals